Authors: KRATOCHWIL NA GUO ZJ MURDOCH PD PARKINSON JA BEDNARSKI PJ SADLER PJ

Citation: Na. Kratochwil et al., ELECTRON-TRANSFER-DRIVEN TRANS-LIGAND LABILIZATION - A NOVEL ACTIVATION MECHANISM FOR PT(IV) ANTICANCER COMPLEXES, Journal of the American Chemical Society, 120(32), 1998, pp. 8253-8254

Authors: KRATOCHWIL NA BEDNARSKI PJ MROZEK H VOGLER A NAGLE JK

Citation: Na. Kratochwil et al., PHOTOLYSIS OF AN IODOPLATINUM(IV) DIAMINE COMPLEX TO CYTOTOXIC SPECIES BY VISIBLE-LIGHT, Anti-cancer drug design, 11(2), 1996, pp. 155-171

Authors: KRATOCHWIL NA ZABEL M RANGE KJ BEDNARSKI PJ

Citation: Na. Kratochwil et al., SYNTHESIS AND X-RAY CRYSTAL-STRUCTURE OF TRANS,CIS-[PT(OAC)(2)I-2(EN)] - A NOVEL TYPE OF CISPLATIN ANALOG THAT CAN BE PHOTOLYZED BY VISIBLE-LIGHT TO DNA-BINDING AND CYTOTOXIC SPECIES IN-VITRO, Journal of medicinal chemistry, 39(13), 1996, pp. 2499-2507

Authors: OTTO AM KRATOCHWIL NA EGGERS H BEDNARSKI PJ

Citation: Am. Otto et al., CHEMICAL-STABILITY, BIOLOGICAL-ACTIVITY AND CELLULAR UPTAKE OF A CISPLATIN ANALOG HAVING A 1,2-DIARYLETHYLENEAMINE LIGAND IN CULTURES OF HUMAN BREAST-CANCER CELLS, Journal of cancer research and clinical oncology, 121(1), 1995, pp. 31-38

Authors: BEDNARSKI PJ KRATOCHWIL NA OTTO AM

Citation: Pj. Bednarski et al., REVERSIBLE AND IRREVERSIBLE INTERACTIONS OF A CISPLATIN ANALOG BEARING A 1,2-DIPHENYLETHYLENEDIAMINE LIGAND WITH PLASMA AND PLASMA-PROTEINSIN-VITRO, Drug metabolism and disposition, 22(3), 1994, pp. 419-427